Tokyo Tape
Sign in
← Fukuda Denshi

Quarterly report · Q1

6960.TEDINET S100OV56
Period2022-04-01 → 2022-06-30
Filed2022-08-05
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥27.7bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥132.1bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥27.6bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥4.0bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥4.2bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥4.4bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥23.4bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.3bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥4.4bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥4.3bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥2.9bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥16.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.8bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.9bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥2.8bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥191.7bnat 2022-06-30Cons.Assets
Total assets¥195.5bnat 2022-03-31Cons.Assets
Total assets¥182.0bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥41.9bnat 2022-06-30Cons.Liabilities
Total liabilities¥45.6bnat 2022-03-31Cons.Liabilities
Net assets / equity¥149.8bnat 2022-06-30Cons.Net assets
Net assets / equity¥149.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥137.5bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥64.0bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥64.1bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥188.542022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥1,072.382021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥183.312021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio78.1%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio76.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio75.5%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q1r_E02304-000Consumables And Other Productsreportable segmentrevenue2022-04-01 → 2022-06-30¥7.8bn
jpcrp040300-q1r_E02304-000Consumables And Other Productsreportable segmentrevenue external2022-04-01 → 2022-06-30¥7.8bn
jpcrp040300-q1r_E02304-000Consumables And Other Productsreportable segmentsegment profit2022-04-01 → 2022-06-30¥817m
jpcrp040300-q1r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2022-04-01 → 2022-06-30¥12.7bn
jpcrp040300-q1r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2022-04-01 → 2022-06-30¥12.7bn
jpcrp040300-q1r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.4bn
jpcrp040300-q1r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2022-04-01 → 2022-06-30¥2.1bn
jpcrp040300-q1r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.1bn
jpcrp040300-q1r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2022-04-01 → 2022-06-30¥282m
jpcrp040300-q1r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2022-04-01 → 2022-06-30¥5.1bn
jpcrp040300-q1r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2022-04-01 → 2022-06-30¥5.1bn
jpcrp040300-q1r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2022-04-01 → 2022-06-30¥583m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥27.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥27.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥4.0bn
jpcrp040300-q1r_E02304-000Consumables And Other Productsreportable segmentrevenue2021-04-01 → 2021-06-30¥7.4bn
jpcrp040300-q1r_E02304-000Consumables And Other Productsreportable segmentrevenue external2021-04-01 → 2021-06-30¥7.4bn
jpcrp040300-q1r_E02304-000Consumables And Other Productsreportable segmentsegment profit2021-04-01 → 2021-06-30¥931m
jpcrp040300-q1r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2021-04-01 → 2021-06-30¥12.7bn
jpcrp040300-q1r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2021-04-01 → 2021-06-30¥12.7bn
jpcrp040300-q1r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2021-04-01 → 2021-06-30¥2.3bn
jpcrp040300-q1r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2021-04-01 → 2021-06-30¥2.6bn
jpcrp040300-q1r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2021-04-01 → 2021-06-30¥2.6bn
jpcrp040300-q1r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2021-04-01 → 2021-06-30¥344m
jpcrp040300-q1r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2021-04-01 → 2021-06-30¥5.0bn
jpcrp040300-q1r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2021-04-01 → 2021-06-30¥5.0bn
jpcrp040300-q1r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2021-04-01 → 2021-06-30¥597m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥27.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥27.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥4.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 365
ItemContextValueUnit
Provision for product warrantiesPrior1YearInstant117000000JPY
Provision for product warrantiesCurrentQuarterInstant122000000JPY
Other provision clPrior1YearInstant579000000JPY
Other provision clCurrentQuarterInstant153000000JPY
Other clPrior1YearInstant7339000000JPY
Other clCurrentQuarterInstant11683000000JPY
Current liabilitiesPrior1YearInstant38829000000JPY
Current liabilitiesCurrentQuarterInstant35206000000JPY
Net defined benefit liabilityPrior1YearInstant3137000000JPY
Net defined benefit liabilityCurrentQuarterInstant3158000000JPY
Other provision nclPrior1YearInstant752000000JPY
Other provision nclCurrentQuarterInstant649000000JPY
Other nclPrior1YearInstant2918000000JPY
Other nclCurrentQuarterInstant2909000000JPY
Noncurrent liabilitiesPrior1YearInstant6809000000JPY
Noncurrent liabilitiesCurrentQuarterInstant6716000000JPY
LiabilitiesPrior1YearInstant45638000000JPY
LiabilitiesCurrentQuarterInstant41923000000JPY
Capital stockPrior1YearInstant4621000000JPY
Capital stockCurrentQuarterInstant4621000000JPY
Capital surplusPrior1YearInstant21841000000JPY
Capital surplusCurrentQuarterInstant21841000000JPY
Retained earningsPrior1YearInstant142135000000JPY
Retained earningsCurrentQuarterInstant141862000000JPY
Treasury stockPrior1YearInstant-20362000000JPY
Treasury stockCurrentQuarterInstant-20357000000JPY
Shareholders equityPrior1YearInstant148236000000JPY
Shareholders equityCurrentQuarterInstant147967000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant1836000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant1771000000JPY
Foreign currency translation adjustmentPrior1YearInstant-11000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant252000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-204000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-193000000JPY
Valuation and translation adjustmentsPrior1YearInstant1621000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant1830000000JPY
Net assetsPrior1YearInstant149857000000JPY
Net assetsCurrentQuarterInstant149798000000JPY
Liabilities and net assetsPrior1YearInstant195495000000JPY
Liabilities and net assetsCurrentQuarterInstant191721000000JPY
Net salesPrior1YTDDuration27587000000JPY
Net salesCurrentYTDDuration27690000000JPY
Cost of salesPrior1YTDDuration13244000000JPY
Cost of salesCurrentYTDDuration12828000000JPY
Gross profitPrior1YTDDuration14343000000JPY
Gross profitCurrentYTDDuration14861000000JPY
Selling general and administrative expensesPrior1YTDDuration10147000000JPY
Selling general and administrative expensesCurrentYTDDuration10828000000JPY
Operating incomePrior1YTDDuration4195000000JPY
Operating incomeCurrentYTDDuration4033000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass